{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0067-6094",
      "generic_name": "ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE",
      "labeler_name": "Haleon US Holdings LLC",
      "brand_name": "Theraflu PowerPods Daytime Severe Cold",
      "brand_name_suffix": "PowerPods Daytime Severe Cold",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "650 mg/1"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "20 mg/1"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "10 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0067-6094-01",
          "description": "8 POUCH in 1 CARTON (0067-6094-01)  / 1 POWDER, FOR SOLUTION in 1 POUCH (0067-6094-02)",
          "marketing_start_date": "20180728",
          "sample": false
        },
        {
          "package_ndc": "0067-6094-03",
          "description": "1 POUCH in 1 CARTON (0067-6094-03)  / 1 POWDER, FOR SOLUTION in 1 POUCH",
          "marketing_start_date": "20190120",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Haleon US Holdings LLC"
        ],
        "rxcui": [
          "1659967"
        ],
        "spl_set_id": [
          "e655c33c-c319-41d9-ae55-cf747242cd10"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "362O9ITL9D",
          "9D2RTI9KYH",
          "04JA59TNSJ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "POWDER, FOR SOLUTION",
      "spl_id": "132d9efd-0e0c-a2c7-e063-6294a90a1fe1",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180728",
      "product_id": "0067-6094_132d9efd-0e0c-a2c7-e063-6294a90a1fe1",
      "application_number": "M012",
      "brand_name_base": "Theraflu",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}